Ketamine as a Treatment Option for Severe Borderline Personality Disorder
Journal of Clinical Psychopharmacology December 30, 2022 Helena Rogg, Mihai Avram, Felix Müller et al. 8 citations
Ketamine treatment in patients with borderline personality disorder (BPD) may reduce symptom severity, but the evidence is preliminary and based on small samples. The review suggests that ketamine could be a potential therapeutic option for BPD, particularly for comorbid depression, though more rigorous studies are needed to confirm efficacy and safety. The authors note that existing studies have significant limitations, including lack of control groups and short follow-up periods.